韩治伟,张丽芳,郑金刚

• 1:中日友好医院心脏内科

摘要(Abstract)：

<正>随着慢性肾病(chronic kidenydidease,CKD)发病率的逐渐升高,CKD患者的生存时间延长,进入到透析阶段的终末期肾病(end stage renal disease,ESRD)患者也有逐渐增加趋势。ESRD患者合并冠心病是很常见的临床情况,随着药物治疗和血运重建方式的发展,普通人群中冠心病的预后有所改善,但合并ESRD的冠心病患者的诊治仍然是临床医生经

关键词(KeyWords)： 终末期肾病;冠心病;血运重建

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 韩治伟,张丽芳,郑金刚

参考文献(References)：

• [1]Cheung AK,Sarnak MJ,Yan G,et al.Cardiac diseases in maintenance hemodialysis patients:results of the HEMO Study.Kidney Int,2004,65:2380-2389.
• [2]Sarnak MJ,Levey AS,Schoolwerth AC,et al.Kidney disease as a risk factor for development of cardiovascular disease:a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease,High Blood Pressure Research,Clinical Cardiology,and Epidemiology and Prevention.Circulation,2003,108:2154-2169.
• [3]Weiner DE,Tighiouart H,Elsayed EF,et al.The Framingham predictive instrument in chronic kidney disease.J Am Coll Cardiol,2007,50:217-224.
• [4]Moe SM,Chen NX.Pathophysiology of vascular calcification in chronic kidney disease.Cir Res,2004,95:560-567.
• [5]Braun WE,Phillips DF,Vidt DG,et al.Coronary artery disease in 100 diabetics with end-stage renal failure.Transplant Proc,1984,16:603-607.
• [6]Ohtake T,Kobayashi S,Moriya H,et al.High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy:an angiographic examination.J Am Soc Nephrol,2005,16:1141-1148.
• [7]Ragosta M,Samady H,Isaacs RB,et al.Coronary flow reserve abnormalities in patients with diabetes mellitus who have endstage renal disease and normal epicardial coronary arteries.Am Heart J,2004,147:1017-1023.
• [8]Yuda S,Khoury V,Marwick TH.Influence of wall stress and left ventricular geometry on the accuracy of dobutamine stress echocardiography.J Am Coll Cardiol,2002,40:1311-1319.
• [9]Stenvinkel P,Carrero JJ,Axelsson J,et al.Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient:how do new pieces fit into the uremic puzzle?Clin J Am Soc Nephrol,2008,3:505-521.
• [10]Khan NA,Hemmelgarn BR,Tonelli M,et al.Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease:a meta-analysis.Circulation,2005,112:3088-3096.
• [11]Hayashi T,Obi Y,Kimura T,et al.Cardiac troponin T predicts occult coronary artery stenosis in patients with chronic kidney disease at the start of renal replacement therapy.Nephrol Dial Transplant,2008,23:2936-2942.
• [12]Hakeem A,Bhatti S,Chang SM.Screening and risk stratification of coronary artery disease in end-stage renal disease.JACC Cardiovasc Imaging,2014,7:715-728.
• [13]Young LH,Wackers FJ,Chyun DA,et al.Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes:the DIAD study:a randomized controlled trial.JAMA,2009,301:1547-1555.
• [14]Jug B,Papazian J,Gupta M,et al.Diagnostic performance of computed tomographic coronary angiography in patients with endstage renal disease.Coron Artery Dis,2013,24:135-141.
• [15]Kato S,Chmielewski M,Honda H,et al.Aspects of immune dysfunction in end-stage renal disease.Clin J Am Soc Nephrol,2008,3:1526-1533.
• [16]Stenvinkel P,Alvestrand A.Inflammation in end-stage renal disease:sources,consequences,and therapy.Semin Dial,2002,15:329-337.
• [17]Parekh RS,Plantinga LC,Kao WH,et al.The association of sudden cardiac death with inflammation and other traditional risk factors.Kidney Int,2008,74:1335-1342.
• [18]Mach F,Schnbeck U,Bonnefoy JY,et al.Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40:induction of collagenase,stromelysin,and tissue factor.Circulation,1997,96:396-399.
• [19]Ridker PM,Danielson E,Fonseca FA,et al.Rosuvastatin to prevent vascular events in men and women with elevated Creactive protein.N Engl J Med,2008,359:2195-2207.
• [20]Taylor AJ,Merz CN,Udelson JE.34th Bethesda Conference:executive summary-can atherosclerosis imaging techniques improve the detection of patients at risk for ischemic heart disease?J Am Coll Cardiol,2004,41:1860-1862.
• [21]Pundziute G,Schuijf JD,Jukema W,et al.Prognostic Value of Multislice Computed Tomography Coronary Angiography in Patients With Known or Suspected Coronary Artery Disease.J Am Coll Cardiol,2007,49:62-70.
• [22]Raggi P,Boulay A,Chasan-Taber S,et al.Cardiac calcification in adult hemodialysis patients.A link between end-stage renal disease and cardiovascular disease?J Am Coll Cardiol,2002,39:695-701.
• [23]Hujairi NM,Afzali B,Goldsmith DJ.Cardiac calcification in renal patients:what we do and don't know.Am J Kidney Dis,2004,43:234-243.
• [24]Schwarz U,Buzello M,Ritz E,et al.Morphology of coronary atherosclerotic lesions in patients with endstage renal failure.Nephrol Dial Transplant,2000,15:218-223.
• [25]Kalandar-Zadeh K,Block G,Humphreys MH,et al.Reverse epidemioliogy of cardiovascular risk factors in maintenance dialysis patients.Kidney Int,2003,63:793-808.
• [26]Vattikuti R,Towler DA.Osteogenic regulation of vascular calcification:an early perspective.Am J Physiol Endocrinol Metab,2004,286:E686-E696.
• [27]Mc Cullough PA,Sandberg KR,Dumler F,et al.Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease:a systematic review.J Nephrol,2004,17:205-215.
• [28]Chonchol M,Whittle J,Desbien A,et al.Chronic kidney disease is associated with angiographic coronary artery disease.Am J Nephrol,2008,28:354-360.
• [29]Gurm HS,Gore JM,Anderson FA Jr.,et al.Comparison of acute coronary syndrome in patients receiving versus not receiving chronic dialysis(from the Global Registry of Acute Coronary Events[GRACE]Registry).Am J Cardiol,2012,109:19-25.
• [30]Herzog CA,Ma JZ,Collins AJ.Poor long-term survival after acute myocardial infarction among patients on long-term dialysis.N Engl J Med,1998,339:799-805.
• [31]Labrousse L,de Vincentiis C,Madonna F,et al.Early and long term results of coronary artery bypass grafts in patients with dialysis dependent renal failure.Eur J Cardiothorac Surg,1999,15:691-696.
• [32]Coca SG,Krumholz HM,Garg AX,et al.Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease.JAMA,2006,296:1377-1384.
• [33]Hemmelgarn BR,Southern D,Culleton BF,et al.Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease(APPROACH)Investigators:Survival after coronary revascularization among patients with kidney disease.Circulation,2004,110:1890-1895.
• [34]Eisenstein EL,Sun JL,Anstrom KJ,et al.Assessing the economic attractiveness of coronary artery revascularization in chronic kidney disease patients.J Med Syst,2009,33:287-297.
• [35]Herzog CA,Ma JZ,Collins AJ.Long-term outcome of dialysis patients in the United States with coronary revascularization procedures.Kidney Int,1999,56:324-332.
• [36]Nevis IF,Mathew A,Novick RJ,et al.Optimalmethod of coronary revascularization in patients receiving dialysis:systematic review.Clin J Am Soc Nephrol,2009,4:369-378.
• [37]Sunagawa G,Komiya T,Tamura N,et al.Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis.Ann Thorac Surg,2010,89:1896-1900.
• [38]Herzog CA,Gilbertson DT,Solid C.Long-term survival of dialysis patients in the US after surgical versus percutaneous coronary revascularization.Circulation,2010,122:A12633.
• [39]Kannan A,Poongkunran C,Medina R,et al.Coronary Revascularization in Chronic and End-Stage Renal Disease:A Systematic Review and Meta-analysis.Am J Ther,2014,[Epub ahead of print].
• [40]Roberts JK,Patel UD.Management of coronary artery disease in end-stage renal disease.Semin Dial,2011,24:525-532.
• [41]Stephan Windecker,Kolh P,Alfonso F,et al.2014 ESC/EACTS Guidelines on myocardial Revascularization.Rev Esp Cardiol(Engl Ed),2015,68:144.
• [42]Aoyama T,Ishii H,Toriyama T,et al.Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis.Circ J,2008,72:56-60.
• [43]Ishio N,Kobayashi Y,Takebayashi H,et al.Impact of drugeluting stents on clinical and angiographic outcomes in dialysis patients.Circ J,2007,71:1525-1529.
• [44]Abdel-Latif A,Mukherjee D,Mesgarzadeh P,et al.Drug-eluting stents in patients with end-stage renal disease:meta-analysis and systematic review of the literature.Catheter Cardiovasc Interv,2010,76:942-948.
• [45]Barbato E,CarriéD,Dardas P,et al.European expert consensus on rotational atherectomy.Euro Intervention,2015,11:30-36.
• [46]Cavusoglu E,Kini AS,Marmur JD,et al.Current status of rotational atherectomy.Catheter Cardiovasc Interv,2004,62:485-498.
• [47]Edes IF,Ruzsa Z,SzabóG,et al.Clinical predictors of mortality following rotational atherectomy and stent implantation in highrisk patients:A single center experience.Catheter Cardiovasc Interv,2015,86:634-641.
• [48]Dill T,Dietz U,Hamm CW,et al.A randomized comparison of balloon angioplasty versus rotational atherectomy in complex coronary lesions(COBRA study).Eur Heart J,2000,21:1759-1766.
• [49]Tomey MI,Kini AS,Sharma SK.Current status of rotational atherectomy.JACC Cardiovasc Interv,2014,7:345-353.
• [50]Kovach JA,Mintz GS,Pichard AD,et al.Sequential intravascular ultrasound characterization of the mechanisms of rotational atherectomy and adjunct balloon angioplasty.J Am Coll Cardiol,1993,22:1024-1032.
• [51]Hiremath S,Holden RM,Fergusson D,et al.Antiplatelet medications in hemodialysis patients:a systematic review of bleeding rates.Clin J Am Soc Nephrol,2009,4:1347-1355.
• [52]Kaufman JS,O'Connor TZ,Zhang JH,et al.Veterans Affairs Cooperative Study Group on Hemodialysis Access Graft Thrombosis:Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis.J Am Soc Nephrol,2003,14:2313-2321.